CANDIDO, SAVERIO
 Distribuzione geografica
Continente #
NA - Nord America 1.760
EU - Europa 1.344
AS - Asia 365
AF - Africa 156
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.629
Nazione #
US - Stati Uniti d'America 1.681
IT - Italia 421
IE - Irlanda 382
CN - Cina 261
UA - Ucraina 195
DE - Germania 128
CI - Costa d'Avorio 108
CA - Canada 79
RU - Federazione Russa 78
VN - Vietnam 59
SN - Senegal 36
SE - Svezia 28
FR - Francia 18
CH - Svizzera 17
GB - Regno Unito 17
IN - India 17
FI - Finlandia 14
NL - Olanda 10
AT - Austria 9
NG - Nigeria 8
IR - Iran 6
SG - Singapore 6
GR - Grecia 5
PL - Polonia 5
UZ - Uzbekistan 5
BE - Belgio 4
PK - Pakistan 4
AU - Australia 3
BG - Bulgaria 3
LB - Libano 3
RO - Romania 3
TN - Tunisia 2
AL - Albania 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
LI - Liechtenstein 1
NO - Norvegia 1
PT - Portogallo 1
TR - Turchia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.629
Città #
Chandler 420
Dublin 375
Jacksonville 277
Catania 145
Abidjan 108
Cambridge 100
Lawrence 100
Andover 91
Grafing 84
Nanjing 82
Toronto 68
Houston 56
Des Moines 55
Wilmington 52
Dong Ket 47
Ashburn 45
Boardman 39
Dakar 36
San Mateo 30
Hebei 27
Nanchang 25
Saint Petersburg 22
Shenyang 19
Beijing 18
Palermo 17
Jiaxing 16
Falls Church 14
Bremen 13
Dearborn 12
Hanoi 12
Padova 12
Ottawa 11
Helsinki 10
Acireale 9
Redwood City 9
Tianjin 9
Abuja 8
Augusta 8
Jinan 8
Norwalk 8
Changsha 7
Leawood 7
Mascalucia 7
Den Haag 6
Frankfurt Am Main 6
Redmond 6
Ardabil 5
Maletto 5
Ningbo 5
Brussels 4
Edinburgh 4
Lappeenranta 4
Mumbai 4
Syracuse 4
Zhengzhou 4
Amsterdam 3
Ann Arbor 3
Capo D'orlando 3
Guangzhou 3
Hangzhou 3
Kunming 3
Messina 3
Milan 3
Moscow 3
Pune 3
Rosolini 3
San Diego 3
San Francisco 3
Seattle 3
Vicenza 3
Bahadurgarh 2
Bari 2
Barletta 2
Boston 2
Cagliari 2
Canicattì 2
Castelnuovo Magra 2
Craiova 2
Florence 2
Fuzhou 2
Lentini 2
Los Angeles 2
Melbourne 2
Menlo Park 2
Misterbianco 2
Mountain View 2
Napoli 2
New York 2
Norderstedt 2
Paris 2
Providence 2
Reggio Calabria 2
Rescaldina 2
Romans D'isonzo 2
Rome 2
San Giuliano Milanese 2
Simmern 2
Singapore 2
Taormina 2
Turin 2
Totale 2.680
Nome #
Gut Microbiota and Cancer: From Pathogenesis to Therapy 151
Prognostic significance of deregulated microRNAs in uveal melanomas 71
Computational modelling in melanoma for novel drug discovery 64
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells 63
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 62
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma 61
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease 58
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 56
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 56
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 56
Advances in targeting signal transduction pathways. 55
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 55
MMP-9 as a marker-of response to treatment with B-Raf inhibitors in cutaneous melanoma 54
Abstract 5305: DNA methylation and gene expression in melanoma: A large-scale integrated analysis 54
Analysis of the RAC1 mutations in cutaneous melanoma patients with occupational sun exposure 53
Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development 53
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 52
Cutaneous melanoma: From pathogenesis to therapy 52
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 51
microRNAs and thyroid cancer: Biological and clinical significance (Review). 50
Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer 48
Droplet digital pcr analysis of liquid biopsy samples unveils the diagnostic role of hsa-mir-133a-3p and hsa-mir-375-3p in oral cancer 48
Analysis of the B-RafV600E mutation in cutaneous melanoma patients with occupational sun exposure 47
Emerging targeted therapies for melanoma treatment (review) 46
Nitric Oxide in Hematological Cancers: Partner or Rival? 46
Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells 45
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 45
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? 45
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression 43
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 43
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 42
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance 42
Pericytes in microvessels: From “mural” function to brain and retina regeneration 42
Targeting signaling pathways involved in metastasis in cancer stem cells 40
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals. 40
Cutaneous melanoma and the immunotherapy revolution (Review) 40
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 39
Suppressing prostate cancer by targeting NGAL 39
BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review) 39
A Tailored Health Surveillance Program Unveils a Case of MALT Lymphoma in a HCV-positive Health-Care Worker 39
Overactivation of IL6 cis‑signaling in leukocytes is an inflammatory hallmark of deep vein thrombosis 39
Patient-derived tumor organoids for drug repositioning in cancer care: A promising approach in the era of tailored treatment 39
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 38
Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells 37
Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis 36
Environment and bladder cancer: Molecular analysis by interaction networks 36
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 35
Overexpression of Sthamin-1 in lung cancer from patients exposed to asbestos: an "in silico" evaluation 34
Functions of NGAL and GSK-3beta in sensitivity to targeted, chemo- and hormonal-based therapies 34
MMP-9 as a candidate marker of response to BRAF inhibitors in melanoma patients with BRAFV600Emutation detected in circulating-free DNA 34
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 34
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals 33
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells 33
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 33
Interaction between matrix metalloproteinase-9 (MMP-9) and neutrophil gelatinase-associated lipocalin (NGAL): A recent evolutionary event in primates 33
Detection of B-Rat mutations in ovarian cancer is associated with chemoresistance 32
Analisi delle mutazioni Rac1 nei lavoratori con melanoma cutaneo esposti al sole per motivi professionali 32
Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey 32
Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study 32
Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma 32
Low levels of inflammation and the absence of subclinical atherosclerosis in rheumatoid arthritis 31
Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment 31
Low Glycemic Index Diet, Exercise and Vitamin D to Reduce Breast Cancer Recurrence: Rationale for the Design of a Clinical Trial 30
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells 30
The tumor microenvironment in hepatocellular carcinoma 30
MMP-9 is a candidate marker of response to treatment with dabrafenib in melanoma cells 29
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 29
Analysis of PIK3CA mutations in cutaneous melanoma patients with occupational sun exposure 29
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression 28
Role of the transcription factor Yin Yang 1 and its selectively identified target survivin in high-grade b-cells non-Hodgkin lymphomas: Potential diagnostic and therapeutic targets 27
V600E B-Raf mutation is associated with chemoresistance in ovarian cancer 26
MMP-9 is down-regulated after treatment with Vemurafenib in A375 and A2058 melanoma cells 26
Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity. 25
Implication of IL-6 in the development of HCV-associated non-Hodgkin lymphoma 25
Transcription analysis of Neutral Associated Lipocalin (NGAL) in Hepatocellular Carcinoma 25
Overexpression of nectin like-5 is associated with a malignant phenotype in cutaneous melanoma 25
The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways 25
Neopterin: a potential marker in chronic peripheral arterial disease. 24
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 24
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases. 24
Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma 24
IL-6-174 G > C and MMP-9-1562 C > T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients. 24
Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer 23
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention 23
Interactions between immune and environmental stimuli in non-Hodgkin Lymphoma 23
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy 22
Molecular Targeted Therapy In Melanoma: A Way To Reverse Resistance To Conventional Drugs. 22
Overexpression of Sthamin-1 is associated with the development of lung cancer developed in patients exposed to asbestos 22
Osteopontin/matrixmetalloproteinasis pathway activation in head and neck cancer 22
Neutrophil gelatinase-associated lipocalin (NGAL) as potential marker of bladder cancer progression 22
Metformin influences drug sensitivity in pancreatic cancer cells 21
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder 21
Cancer therapy and treatments during COVID-19 era 21
YY1 silencing induces 5-fluorouracil-resistance and BCL2L15 downregulation in colorectal cancer cells: Diagnostic and prognostic relevance 21
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals 20
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53 19
Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53 17
Role of microRNAs as novel diagnostic biomarkers and potential therapeutic targets for hearing disorders (Review) 14
Novel insights into epigenetic regulation of il6 pathway: In silico perspective on inflammation and cancer relationship 14
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity 13
Totale 3.724
Categoria #
all - tutte 13.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.649


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201938 0 0 0 0 0 0 0 0 0 0 8 30
2019/2020516 179 51 43 24 62 14 62 2 21 8 35 15
2020/2021623 8 31 62 4 107 33 75 0 109 15 121 58
2021/2022727 62 107 5 33 102 15 100 25 52 23 21 182
2022/20231.326 114 69 30 144 118 201 11 208 321 25 56 29
2023/2024373 20 80 32 27 24 100 25 34 11 20 0 0
Totale 3.797